Italian venture capital firm Panakès Partners, previously active in medtech, has closed the €150m “purple”...
Up To Date
Latest News
Mainz-based BioNTech is expanding its portfolio for cancer therapies with the neoantigen TCR Cell Therapy R&D...
Coventry-based NanoSyrinx plc has raised £6.2m in seed financing to develop a new cell engineering tool for...
Dutch immunotherapy company ISA Pharmaceuticals has closed a €26m funding round that will go towards advancing...
As part of its 'Clean Future' strategy, Unilever NV has licensed enzyme technology from Arzeda Inc. to help...
Danish Novo Nordisk is moving out of the diabetes space and taking over Prothena’s ATTR amyloidosis programme...
Share
